Vimal Mehta insider trades

Open-market stock purchases and sales by Vimal Mehta, CEO and President at BioXcel Therapeutics, Inc, from SEC Form 4 filings since Mar 12, 2018.

Recent trades

DateStockTradeValue
Jun 15, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
May 20, 2026BTAI BioXcel Therapeutics, IncSold$21.1K
May 4, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
May 1, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Mar 15, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Mar 14, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Jan 1, 2026BTAI BioXcel Therapeutics, IncBought (not open market)—
Dec 15, 2025BTAI BioXcel Therapeutics, IncBought (not open market)—
Dec 14, 2025BTAI BioXcel Therapeutics, IncBought (not open market)—

Companies traded

  • BTAI BioXcel Therapeutics, Inc: 16 buys, 31 sales, last Jun 15, 2026

Get free alerts when Vimal Mehta files a new trade →